Ameriprise’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,327,110
| Closed | -$3.65M | – | 4101 |
|
|
2024
Q3 | $3.65M | Buy |
2,327,110
+234,400
| +11% | +$368K | ﹤0.01% | 2579 |
|
|
2024
Q2 | $3.52M | Buy |
2,092,710
+674,760
| +48% | +$1.13M | ﹤0.01% | 2557 |
|
|
2024
Q1 | $3.4M | Sell |
1,417,950
-472,250
| -25% | -$1.13M | ﹤0.01% | 2601 |
|
|
2023
Q4 | $2.89M | Buy |
1,890,200
+675,522
| +56% | +$1.03M | ﹤0.01% | 2688 |
|
|
2023
Q3 | $1.32M | Buy |
1,214,678
+376,270
| +45% | +$410K | ﹤0.01% | 3018 |
|
|
2023
Q2 | $1.92M | Buy |
+838,408
| New | +$1.92M | ﹤0.01% | 2894 |
|
|
2018
Q4 | – | Sell |
-164,581
| Closed | -$1.76M | – | 3709 |
|
|
2018
Q3 | $1.76M | Buy |
+164,581
| New | +$1.76M | ﹤0.01% | 2856 |
|
|
2017
Q3 | – | Sell |
-76,633
| Closed | -$1.26M | – | 3706 |
|
|
2017
Q2 | $1.26M | Buy |
+76,633
| New | +$1.26M | ﹤0.01% | 2826 |
|
|
2015
Q2 | – | Sell |
-11,280
| Closed | -$11K | – | 4002 |
|
|
2015
Q1 | $11K | Buy |
+11,280
| New | +$11K | ﹤0.01% | 3774 |
|
|
2014
Q4 | – | Sell |
-5,245
| Closed | -$7K | – | 4110 |
|
|
2014
Q3 | $7K | Sell |
5,245
-720
| -12% | -$961 | ﹤0.01% | 4971 |
|
|
2014
Q2 | $10K | Buy |
5,965
+340
| +6% | +$570 | ﹤0.01% | 4643 |
|
|
2014
Q1 | $10K | Buy |
5,625
+640
| +13% | +$1.14K | ﹤0.01% | 4511 |
|
|
2013
Q4 | $9K | Sell |
4,985
-16,010
| -76% | -$28.9K | ﹤0.01% | 4414 |
|
|
2013
Q3 | $50K | Buy |
20,995
+740
| +4% | +$1.76K | ﹤0.01% | 3814 |
|
|
2013
Q2 | $44K | Buy |
+20,255
| New | +$44K | ﹤0.01% | 3789 |
|